Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Randomized, Open-Label, Multicenter, Phase 2 Study of the Combination of VELCADE, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR CAP) or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Subjects With Newly Diagnosed Non-Germinal Center B Cell Subtype of Diffuse Large B-Cell Lymphoma https://kusajili.com:443/Trial/w6EkUTUpaE2Ls_U_iJNVkA%24a-randomized-open-label-multicenter-phase-2-study-of-the-combination-of-velcade-rituximab-cyclophosphamide-doxorubicin-and-pred
I have read and accept the terms of use of the site and the Privacy Policy
Send your message